NCT01581892

Brief Summary

The aim of the study is to determine the safety and feasibility of autologous mononuclear stem cells in long bone nonunion; and moreover, to evaluate the efficacy of the treatment.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
7

participants targeted

Target at below P25 for phase_1

Timeline
Completed

Started Dec 2011

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2011

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

April 9, 2012

Completed
11 days until next milestone

First Posted

Study publicly available on registry

April 20, 2012

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2012

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2013

Completed
Last Updated

August 25, 2015

Status Verified

August 1, 2015

Enrollment Period

9 months

First QC Date

April 9, 2012

Last Update Submit

August 24, 2015

Conditions

Keywords

bone nonunionbone marrowmononuclearfracture

Outcome Measures

Primary Outcomes (1)

  • Absence of adverse effects during timeframe as infections or complications related with the intervention

    The proposed trial will involve the recruitment of a total of 30 patients. The cells will be collected via bone marrow sampling. The aspirate will be centrifuged on a Ficoll density gradient to isolate mononuclear cells, wich will be resuspended in heparinized isotonic saline and used in order to infuse into the area surgically treated. The surgical intervention means the introduction of a sheet with nails according with the usually employed technique.

    Six months

Secondary Outcomes (1)

  • Improvement and union of the bone

    One year

Study Arms (1)

Bone marrow stem cells

EXPERIMENTAL

Bone marrow is obtained by posterosuperior iliac crest aspiration under topical anesthesia. Mononuclear cells were isolated by Ficoll density gradient and will be resuspended in heparinized isotonic saline for mixing with osteogenic matrix.

Procedure: Osteosynthesis

Interventions

To mix the cell suspension with osteogenic matrix and to use sheet and nails in order to consolidate the fracture

Also known as: bone nonunion, bone marrow, mononuclear, fracture
Bone marrow stem cells

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • diagnosed long bone nonunion
  • age from 18 years old

You may not qualify if:

  • active infection
  • cancer patients
  • concomitant serious illness
  • pregnant women
  • evidences of mental illness
  • previous alcohol or drug dependences
  • previous malignant disease during last 5 years, except for basal carcinoma

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital Universitario Central de Asturias

Oviedo, Principality of Asturias, 33006, Spain

Location

Related Publications (1)

  • Fernandez-Bances I, Perez-Basterrechea M, Perez-Lopez S, Nunez Batalla D, Fernandez Rodriguez MA, Alvarez-Viejo M, Ferrero-Gutierrez A, Menendez-Menendez Y, Garcia-Gala JM, Escudero D, Paz Aparicio J, Carnero Lopez S, Lopez Fernandez P, Gonzalez Suarez D, Otero Hernandez J. Repair of long-bone pseudoarthrosis with autologous bone marrow mononuclear cells combined with allogenic bone graft. Cytotherapy. 2013 May;15(5):571-7. doi: 10.1016/j.jcyt.2013.01.004. Epub 2013 Feb 14.

    PMID: 23415918BACKGROUND

MeSH Terms

Conditions

Fractures, Bone

Interventions

Fracture Fixation, Internalleukocyte procoagulant activity

Condition Hierarchy (Ancestors)

Wounds and Injuries

Intervention Hierarchy (Ancestors)

Fracture FixationOrthopedic ProceduresTherapeuticsSurgical Procedures, Operative

Study Officials

  • Jesus Otero, MD

    Unidad de Coordinación de Trasplantes, Terapia Celular y Medicina Regenerativa

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 1
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 9, 2012

First Posted

April 20, 2012

Study Start

December 1, 2011

Primary Completion

September 1, 2012

Study Completion

January 1, 2013

Last Updated

August 25, 2015

Record last verified: 2015-08

Locations